|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 3.060 USD | -3.77% |
|
+10.67% | +60.21% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 376M | - | - | - | ||
| 64.69B | |||||
| 54.78B | |||||
| 53.49B | |||||
| 45.98B | |||||
| 42.94B |
- Stock Market
- Stocks
- CCCC Stock
- Charts C4 Therapeutics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
